Table 1.

Listed of compounds approved/clinical trials phase isolated marine sources.

Clinical Status	Compound Name	Refs.
FDA-EMA Approved	Cytarabine, ARA-C	Candida et al., 2012
	Trabectedin	Gajdos et al., 2011
	Brentuximab vedotin	Hemant and Kritarth (2018)
Phase III	Plitidepsin	Michael et al., 2019
	Neovastat®	Falardeau et al., 2001
	Pseudopterosins	Caplan et al., 2016
Phase I/II	Gemcitabine	Van et al., 2018
	Elisidepsin	Petty et al., 2016
	Kahalalide-F	Martín-Algarra et al., 2009
	PM1004	Mandin and Gottesman (2009)
Phase I	Hemiasterlin	Lesma et al., 2014
	Taltobulin	Arie et al. 2005
	Spisulosine	Vilar et al., 2012
	Bryostatin 1	Clamp et al., 2002